Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma.

Küçük Resim Yok

Tarih

2023

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Lippincott Williams & Wilkins

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

[Abstract Not Available]

Açıklama

Anahtar Kelimeler

Metastatic Urothelial Carcinoma, Checkpoint Inhibitors, Long-Term Overall Survival, Objective Response

Kaynak

Genitourinary Cancers Symposium

WoS Q Değeri

Q1

Scopus Q Değeri

Cilt

41

Sayı

Supplement: 6

Künye

Tural, D., Arslan, Ç., Selçukbiricik, F., Ölmez, Ö. F., Akar, E., Erman, M. ... Kılıçkap, S. (2023). Comparison of objective response rate and long-term overall survival in patients with treated immune checkpoint inhibitors in metastatic urothelial carcinoma. Genitourinary Cancers Symposium. Electrical Network, 16-18 February, 2023.